Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Effect of combination endocrine therapy (LHRH agonist and flutamide) on normal prostate and prostatic adenocarcinoma. A histopathologic and immunohistochemical study.

Têtu B, Srigley JR, Boivin JC, Dupont A, Monfette G, Pinault S, Labrie F.

Am J Surg Pathol. 1991 Feb;15(2):111-20.

PMID:
1989458
2.

Immunohistochemistry in diagnostic surgical pathology of the prostate.

Hameed O, Humphrey PA.

Semin Diagn Pathol. 2005 Feb;22(1):88-104. Review.

PMID:
16512601
3.

The morphologic changes induced by hormone and radiation therapy on prostate carcinoma.

Roznovanu SL, Rădulescu D, Novac C, Stolnicu S.

Rev Med Chir Soc Med Nat Iasi. 2005 Apr-Jun;109(2):337-42. Review.

PMID:
16607796
4.

[New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].

Labrie F, Dupont A, Belanger A, Lefebvre FA, Raynaud JP.

J Pharmacol. 1983;14 Suppl 3:117-35. Review. French.

PMID:
6423907
5.

Pseudobenign prostate carcinomas: causes of false-negative biopsy results.

Dema A, Tăban S, Lazăr E, Borda A, Lăzureanu C, Herman D, Mureşan A, Cornianu M, Anderco D, Loghin A.

Rom J Morphol Embryol. 2011;52(3 Suppl):963-74. Review.

6.

[Endometrioid adenocarcinoma of the prostate. Apropos of a case, review of the literature].

Kaskas M, Sauvage L, Hattab B.

J Urol (Paris). 1992;98(2):108-11. Review. French.

PMID:
1431184
7.

Treatment effects in the prostate including those associated with traditional and emerging therapies.

Evans AJ, Ryan P, Van derKwast T.

Adv Anat Pathol. 2011 Jul;18(4):281-93. doi: 10.1097/PAP.0b013e318220f5b1. Review.

PMID:
21654359
8.

[Non-neoplastic alterations of the prostate. Why should pathologists know them?].

Erbersdobler A.

Pathologe. 2013 Sep;34(5):429-35. doi: 10.1007/s00292-013-1782-1. Review. German.

PMID:
23881236
9.

Morphology of treatment-related changes in the prostate and prostatic cancer.

Volavšek M.

Anal Quant Cytopathol Histpathol. 2015 Feb;37(1):48-56. Review.

PMID:
26072634
10.

The benign mimickers of prostatic acinar adenocarcinoma.

Xu Y, Wang Y, Zhou R, Li H, Cheng H, Wang Z, Zhang J.

Chin J Cancer Res. 2016 Feb;28(1):72-9. doi: 10.3978/j.issn.1000-9604.2016.01.01. Review.

Items per page

Supplemental Content

Write to the Help Desk